Japan· JP-7290407G1034
ガドテリドール
A gadoteridol product containing ガドテリドール, registered in Japan by ブラッコ・ジャパン, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Gadoteridol is registered in 14 of 19 countries.
Countries holding a registration under ATC V08CA04 (gadoteridol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Gadoteridol · ATC V08CA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ガドテリドール
- Manufacturer
- ブラッコ・ジャパン
- Country
- Japan (JP)
- ATC code
- V08CA04
- ATC class
- Gadoteridol
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for gadoteridol.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadoteridol · interactions on record
19 records
- 19 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V08CA04
Gadoteridol, as other registers publish it.
- United StatesGADOTERIDOLSlate Run Pharmaceuticals, LLC
- GermanyProhanceEurocontrast Gmbh
- FinlandProhanceBracco International B.V.
- GermanyProhanceBracco Imaging Deutschland Gmbh
- DenmarkProhanceBracco International B.V.
- FinlandProhanceBracco International B.V.
- NorwayProHanceBracco International B.V.
- United StatesProHanceBRACCO DIAGNOSTICS INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f88117e3-e33a-4b1a-a04c-4f4272b9d25b GET /v1/drugs/f88117e3-e33a-4b1a-a04c-4f4272b9d25b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１３ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "7290407G1034",
"category": "注射薬",
"price_yen": 3757,
"generic_name": "ガドテリドール",
"product_name_jp": null,
"therapeutic_class": "7290",
"transitional_expiry": null
}See everything about gadoteridol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.